125 related articles for article (PubMed ID: 29172777)
1. A novel tumor-activated ALA fusion protein for specific inhibition on the growth and invasion of breast cancer cells MDA-MB-231.
Liu X; Liu X; Sunchen S; Liu M; Shen C; Wu J; Zhao W; Yu B; Liu J
Drug Deliv; 2017 Nov; 24(1):1811-1817. PubMed ID: 29172777
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
[TBL] [Abstract][Full Text] [Related]
3. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of MDA-MB-231 cell line by peptides designed based on uPA.
Tarighi P; Khorramizadeh M; Madadkar-Sobhani A; Ostad S; Ghahremani M
Acta Med Iran; 2015 Jul; 53(7):403-7. PubMed ID: 26520626
[TBL] [Abstract][Full Text] [Related]
6. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
[TBL] [Abstract][Full Text] [Related]
7. Expression and activity analysis of a new fusion protein targeting ovarian cancer cells.
Su M; Chang W; Wang D; Cui M; Lin Y; Wu S; Xu T
Oncol Rep; 2015 Sep; 34(3):1337-44. PubMed ID: 26166362
[TBL] [Abstract][Full Text] [Related]
8. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.
Kunigal S; Lakka SS; Gondi CS; Estes N; Rao JS
Int J Cancer; 2007 Nov; 121(10):2307-16. PubMed ID: 17657740
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cancer cell growth by Tangeretin flavone in drug-resistant MDA-MB-231 human breast carcinoma cells is facilitated via targeting cell apoptosis, cell cycle phase distribution, cell invasion and activation of numerous Caspases.
Fan S; Xu H; Liu H; Hu Z; Xiao J; Liu H
J BUON; 2019; 24(4):1532-1537. PubMed ID: 31646804
[TBL] [Abstract][Full Text] [Related]
10. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
[TBL] [Abstract][Full Text] [Related]
11. Expression and purification of recombinant ATF-mellitin, a new type fusion protein targeting ovarian cancer cells, in P. pastoris.
Su M; Chang W; Zhang K; Cui M; Wu S; Xu T
Oncol Rep; 2016 Feb; 35(2):1179-85. PubMed ID: 26718643
[TBL] [Abstract][Full Text] [Related]
12. Cisatracurium inhibits the proliferation, migration and invasion of breast cancer cells by regulating the expression of miR-3174.
Yang X; Ma W
Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):1-7. PubMed ID: 33040777
[TBL] [Abstract][Full Text] [Related]
13. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
Moreau M; Mourah S; Dosquet C
Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
[TBL] [Abstract][Full Text] [Related]
14. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion.
Guo Y; Pakneshan P; Gladu J; Slack A; Szyf M; Rabbani SA
J Biol Chem; 2002 Nov; 277(44):41571-9. PubMed ID: 12198113
[TBL] [Abstract][Full Text] [Related]
15. Urokinase is a negative modulator of Egf-dependent proliferation and motility in the two breast cancer cell lines MCF-7 and MDA-MB-231.
Kozlova N; Samoylenko A; Drobot L; Kietzmann T
Mol Carcinog; 2016 Feb; 55(2):170-81. PubMed ID: 25641046
[TBL] [Abstract][Full Text] [Related]
16. Antitumor Effects of Ruyiping on Cell Growth and Metastasis in Breast Cancer.
Li Z; Sun X; Liu X; Sun Z; Li J
Cancer Biother Radiopharm; 2019 Jun; 34(5):297-305. PubMed ID: 30901274
[No Abstract] [Full Text] [Related]
17. The Enhanced Cytotoxic Effects of the p28-Apoptin Chimeric Protein As A Novel Anti-Cancer Agent on Breast Cancer Cell Lines.
Noei A; Nili-Ahmadabadi A; Soleimani M
Drug Res (Stuttg); 2019 Feb; 69(3):144-150. PubMed ID: 30060264
[TBL] [Abstract][Full Text] [Related]
18. A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.
Liu D; Zhou D; Wang B; Knabe WE; Meroueh SO
ACS Chem Biol; 2015 Jun; 10(6):1521-34. PubMed ID: 25671694
[TBL] [Abstract][Full Text] [Related]
19. High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells.
Flores-López LA; Martínez-Hernández MG; Viedma-Rodríguez R; Díaz-Flores M; Baiza-Gutman LA
Cell Oncol (Dordr); 2016 Aug; 39(4):365-78. PubMed ID: 27106722
[TBL] [Abstract][Full Text] [Related]
20. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells.
Amir S; Margaryan NV; Odero-Marah V; Khalkhali-Ellis Z; Hendrix MJ
Cancer Biol Ther; 2005 Apr; 4(4):400-6. PubMed ID: 15846059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
